Giorgos Papanastasiou
University of Essex
Short Bio
Giorgos Papanastasiou is a research scientist at Pfizer and principal investigator at the Archimedes Unit, of the Athena Research Centre, Greece.
He was Faculty Assistant Professor at the University of Essex (UK, 2020-2022) and Faculty Research Fellow at the University of Edinburgh (UK, 2016-2020). He obtained his PhD and MSc by Research from the University of Edinburgh, MSc from the National Technical University of Athens, and MEng from the School of Engineering at the University of Ioannina. He has attracted funding from diverse bodies such as Athersys (as PI), the “Archimedes” grant (as PI) from NextGenerationEU, Horizon Europe IHI (as work package PI lead on the major OPTIMA IHI project), MRC and Hangshou City Council (as co-I), EPSRC, GE Healthcare, GlaxoSmithKline (as Research Fellow) and the prestigious BHF (PhD studentship).
He has led the development and submission of 23 successful grant applications, attracting > 3,000,000 € in direct funding. He is a leading expert in multimodal artificial intelligence, specializing in generative AI, machine learning, causal AI, mathematical modeling, medical image analysis, and pharmacokinetic modeling, bridging the gap between fundamental research and impactful industrial applications. Giorgos possesses over 90 scientific publications, including numerous articles in high-impact, peer-reviewed journals such as npj Digital Medicine, Nature Communications, IEEE Journal of Biomedical and Health Informatics (where he also serves as Associate Editor), Medical Image Analysis, Information Fusion, IEEE Transactions on Medical Imaging, IEEE Transactions on Industrial Informatics and NeuroImage, as well as conference papers at top-tier international conferences like NeurIPS and MICCAI. His work continues to drive innovation at the intersection of AI advancements, data science, and healthcare applications, tackling complex challenges in areas ranging from drug discovery and clinical trial optimization to early disease diagnosis and personalized medicine across cardiovascular, oncological, neurological, and rare diseases.
Prospective students can email Dr Papanastasiou at
